Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
Recruiting now · Not applicable · Has a placebo group
Conditions studied: Pain
In brief
Multi-center, randomized, blinded, sham-controlled study to determin the safety and efficacy of the NOVABLOC system on post-operative pain in patients undergoing TKA procedures.
Key facts
- Study ID
- NCT07191067
- Run by
- Synaptrix, Inc.
- People needed
- 120
- Starts
- 2025-09-30
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-05-29
Who can join
Age: 21 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or non-pregnant females age ≥ 21 years of age;
- Has an underlying diagnosis of osteoarthritis indicated for a primary unilateral TKA according to established treatment guidelines;
- Able and willing to provide and document informed consent and Authorization for Release of Protected Health Information (PHI);
- Able and willing to comply with all trial tests, procedures, assessments, and follow-up visits for up to 45 days.
- Able to read and understand instructions and information presented in English.
You may not qualify if…
- Chronic opioid use (average ≥ 30 oral morphine equivalents / day) ≤ thirty (30) days of the TKA procedure;
- Extended-release or long-acting opioid (e.g. buprenorphine, Morphine ER, etc.) use ≤ thirty (30) days of the TKA procedure;
- History of substance abuse or misuse;
- History of significant cardiac disease (e.g. ejection fraction ≤ 50%; coronary intervention ≤ six (6) months; significant valvular abnormalities);
- Prior radiofrequency ablation or cryotherapy for pain on the operative knee;
- Prior TKA on the operative knee;
- BMI > 40;
- History of neurological, neuromuscular or neuropathic disease that would confound the study results, including chronic pain conditions;
- Have an active implanted biomedical device (such as cardiac pacemaker, insulin pump, pain stimulator, implantable cardioverter defibrillator) or cochlear [ear] stimulator);
- History of hip or knee dislocation or bone fractures on the operative leg;
- Sepsis or systemic infectious illness; local infection of skin or subcutaneous tissues where procedural access is required including thigh, hip or groin;
- Concomitant medical or psychiatric illness that could compromise evaluation or treatment, including anxiety (GAD-7 score >10) or depression (PHQ-9 score >15);
- Pregnant, actively planning a pregnancy or breast-feeding a child;
- Uncontrolled diabetes (A1C > 7.5%);
- History of bleeding disorder;
- Participating in another clinical trial/investigation within 45 days prior to signing informed consent.
Where it is running
- Alabama Orthopedic Sports Medicine & Baldwin County Surgery Center — Daphne, Alabama, United States (enrolling)
- University of North Carolina — Chapel Hill, North Carolina, United States (enrolling)
- Southern Oregon Orthopedics — Medford, Oregon, United States (enrolling)
- Virginia Mason Medical Center — Seattle, Washington, United States (enrolling)
- Premier Orthopaedic and Trauma Specialists — Upland, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.